Skip to main content
SpringerLink
Log in

Isα-methyldopa-type autoimmune hemolytic anemia mediated by interferon-γ?

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

Drug-related autoimmune hemolytic anemia appearing with warm-reacting antibodies can be classified according to the offending substances. One of the subtypes can be induced byα-methyldopa. However, the pathophysiology of the underlying mechanism is not yet known. In parallel, patients with Parkinson's disease and other extrapyramidal disorders, who are under administration of dopaminergic drugs, often present with abnormal findings with respect to immune parameters. In order to reveal further mechanisms within the immune response, the capability of patients under dopaminergic medication to release cytokines after a stimulatory signal was examined. Therefore, 18 patients who were treated with the dopamine analogue lisuride were compared with an aged-matched control group of 21 healthy volunteers. After stimulation with phytohemagglutinin (PHA), mitogen-induced concentrations of interferon-γ were significantly higher in the patients treated with lisuride than in the control group. Interferon-γ leads to an upregulation of MHC class-I and especially class-II molecules on antigen-presenting cells and to an induction of antibody production in B cells. This condition can result in the induction of an autoimmune process. It might be supposed thatα-methyldopa-type autoimmune hemolytic anemia is me diated by elevated levels of interferon-γ produced in T cells after a stimulatory signal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Article 01 August 2014

References

  1. Baier J, Neumann HA, Ricken D (1991) No inhibition of interferon-gamma release in human lymphocytes by Ciamexone. Cancer Immunol Immunother 32:311–314

    PubMed  Google Scholar 

  2. Bakemeier RF, Leddy JP (1968) Erythrocyte autoantibody associated with alpha-methyldopa: heterogeneity of structure and specificity. Blood 32:1–14

    PubMed  Google Scholar 

  3. Barat M, Conte PH, Hilaire J, Arn L (1977) Am,mie h,molytique auto-immune chez un parkinsonien trait, par assoziationl-dopa-carbidopa. Nouv Presse Med 6:2442

    PubMed  Google Scholar 

  4. Beckenridge A, Dollery CT, Worlledge SM, Holborow EJ, Johnson GD (1967) Positive direct Coombs test and antinuclear factors in patients treated with methyldopa. Lancet 2:1265

    PubMed  Google Scholar 

  5. Benraad AH, Schoemaker AH (1965) Thrombopenia after use of methyldopa. Lancet 2:292

    Google Scholar 

  6. Bonnem EM, Oldham R (1987) Gamma-interferon: physiology and speculation on its role in medicine. J Biol Response Mod 3:275–301

    Google Scholar 

  7. Carstairs KC, Breckenridge A, Dollery CT, Worlledge SM (1966) Incidence of a positive direct Coombs test in patients on alpha-methyldopa. Lancet 2:133–135

    PubMed  Google Scholar 

  8. Freedman AL, Barr PS, Brody E (1956) Hemolytic anemia due to quinidine. Observations on its mechanism. Am J Med 20:806–811

    PubMed  Google Scholar 

  9. Goldstein GB, Lam KC, Mistilis SP (1973) Drug-induced active chronic hepatitis. Am J Dig Dis 18:177–184

    PubMed  Google Scholar 

  10. Henry RE, Goldberg LS, Sturgeon P, Ansel RD (1971) Serologic abnormalities associated withl-dopa therapy. Vox Sang 20:306–316

    PubMed  Google Scholar 

  11. Kim KJ, Chaouat G, Leiserson WM, King J, De Maeyer E (1983) Characterization of T-cell soluble factors modulating the expression of 1A and H2 antigens on BALB-c B-lymphoma cell lines. Cell Immunol 76:253–267

    PubMed  Google Scholar 

  12. Kirtland HH, Mohler DN, Horwitz DA (1980) Methyldopa inhibition of suppressor-lymphocyte function. A proposed cause of autoimmune hemolytic anemia. N Engl J Med 302:825–832

    PubMed  Google Scholar 

  13. LoBuglio AF, Jandl JH (1967) The nature of alpha-methyldopa red cell antibody. N Engl J Med 276:658–665

    PubMed  Google Scholar 

  14. Malaise MG, Bastings M, Reuter AM, Vrints-Gevaert Y, Bernier J, Sondag D, Frere MC, Goldstein G, Franchimont P (1987) In vitro effects of thymopentin onγ-interferon poduction by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritis. Immunol Lett 15:323–327

    PubMed  Google Scholar 

  15. Marttila R, Escola J, Päivärinta M, Rinne U (1984) Immune functions in parkinsons disease. Adv Neurol 40:315–323

    PubMed  Google Scholar 

  16. Marttila R, Escola J, Soppi E, Rinne U (1985) Immune functions in parkinsons disease — lymphocytes subsets, concanavalin A induced suppressor cell activity and in vitro immunoglobulin production. J Neurol Sci 69:121–131

    PubMed  Google Scholar 

  17. Murray HW, Rubin BY, Masur H, Roberts RB (1984) Impaired production of lymphokines and immune: (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 310:883–889

    PubMed  Google Scholar 

  18. Paganelli R, Capobianchi MR, Matricardi PM, Cloe L, Seminara R, Dianzani F, Aiuti F (1984) Defective interferon-gamma production in ataxiateleangiectatica. Clin Immunol Immunopathol 32:387–391

    PubMed  Google Scholar 

  19. Roberts WK, Vasil A (1982) Evidence for identity of murine gamma interferon and macrophage activating factor. J Interferon Res 2:519–532

    PubMed  Google Scholar 

  20. Robertson JH, Kennedy CC, Hill CM (1971) Haemolytic anaemia associated with mefenamic acid. Ir J Med Sci 140:226–229

    PubMed  Google Scholar 

  21. Romagni S, Giudizi MG, Biagiotti R, Almerigogna F, Mingari C, Maggi E, Liang CM, Moretta L (1 986) B-cell growth factor activity of interferon-gamma. Recombinat interferongamma promotes proliferation of anti-mu-activated human B lymphocytes. J Immunol 136:3513–3516

    Google Scholar 

  22. Ross F, Fellous M (1984) The effect of gamma-interferon on MHC antigens. Immunol Today 5:261–268

    Google Scholar 

  23. Samid D, Chang EH, Friedman RM (1984) Biochemical correlations of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene. Biochem Biophys Res Comm 119:21–28

    PubMed  Google Scholar 

  24. Schubothe H, Maas D, Weber S, Ralf W, Marsovsky E, Herberg D (1982) Methyldopainduzierte autoimmunhämolytische Anämien. Immun Infekt 10:230–239

    PubMed  Google Scholar 

  25. Sidman CL, Marshall JD, Shultz LD, Gray PW, Johnson HM (1984) Gamma interferon is one of several direct B-cell maturating lymphokines. Nature 309:801–804

    PubMed  Google Scholar 

  26. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russel PS (1985) Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med 162:1645–1664

    PubMed  Google Scholar 

  27. Taylor-Papadimitriou J (1984) Effects of interferons on cell growth and function. In: Billiau A (ed) Interferon, vol. 1. General and applied aspects. Elsevier Science, Amsterdam, pp 48–51

    Google Scholar 

  28. VanArsdel PP, Gilliland BC (1965) Anemia secondary to penicillin treatment. Studies on two patients with non-allergic serum hemagglutinins. J Lab Clin Med 65:277–285

    PubMed  Google Scholar 

  29. Vilcek J, Klion A, Hendriksen-Destefano D, Zemtsov A, Davidson DM, Davidson M, Friedman-Kien AE, Le J (1986) Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol 6:146–151

    PubMed  Google Scholar 

  30. Wheelock EF (1965) Interferon-like virus inhibitor induced in human leukocytes by phytohemagglutinin. Science 149:310–311

    Google Scholar 

  31. Wong GHW, Clark-Lewisl, McKimm-Breschkin JL, Harris AW, Schrader JW (1983) Interferon-gamma induces enhanced expression of 1A antigens and H2 antigens pn B-lymphoid, macrophage, and myeloid cell lines. J Immunol 131:788–793

    PubMed  Google Scholar 

  32. Worlledge SM (1973) Immune drug-induced hemolytic anemias. Semin Hematol 10:327–344

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik der Ruhr-Universität Bochum, St. Josef Hospital, Gudrunstrasse 56, D-44791, Bochum, Germany

    J. E. Baier

  2. Neurologische Klinik der Ruhr-Universität Bochum, St. Josef Hospital, Gudrunstrasse 56, D-44791, Bochum, Germany

    D. Poehlau

Authors
  1. J. E. Baier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Poehlau
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baier, J.E., Poehlau, D. Isα-methyldopa-type autoimmune hemolytic anemia mediated by interferon-γ?. Ann Hematol 69, 249–251 (1994). https://doi.org/10.1007/BF01700279

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01700279

Key words

Search

Navigation